Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jan. 03, 2014	Dec. 28, 2012
Cash flows from operating activities:
Net loss	$ (5,166)	$ (42,904)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	117,742	98,997
Amortization of intangible assets	18,009	17,720
Deferred income taxes	(20,693)	(30,997)
Stock-based compensation expense	24,365	19,410
Loss on disposition of fixed assets	24,592	7,070
Non-cash loss on extinguishment of debt		6,726
Repayment of discount on 2016 Notes		(3,418)
Receipt of premium on 2020 Notes		10,500
Other non-cash adjustments	4,661	3,256
Increase (decrease) in cash resulting from changes in operating assets and liabilities, net of effect of acquisition:
Accounts receivable	(18,688)	(26,830)
Inventories	(16,470)	1,256
Other assets	(7,059)	(8,920)
Accounts payable	10,801	935
Accrued liabilities	2,063	(12,536)
Other liabilities	749	8,873
Net cash provided by operating activities	134,906	49,138
Cash flows from investing activities:
Purchase of property, equipment and satellites	(244,863)	(120,182)
Cash paid for patents, licenses and other assets	(33,210)	(18,880)
Payment related to acquisition of business, net of cash acquired	(2,400)
Net cash used in investing activities	(280,473)	(139,062)
Cash flows from financing activities:
Proceeds from revolving credit facility borrowings	145,000
Payments of revolving credit facility borrowings	(60,000)
Payment of debt issuance costs	(2,512)	(8,059)
Proceeds from issuance of 2020 Notes		300,000
Repayment of 2016 Notes		(271,582)
Proceeds from issuance of common stock under equity plans	15,776	19,512
Purchase of common stock in treasury	(14,829)	(7,902)
Other	(2,275)	(1,950)
Net cash provided by financing activities	81,160	30,019
Effect of exchange rate changes on cash	31	(11)
Net decrease in cash and cash equivalents	(64,376)	(59,916)
Cash and cash equivalents at beginning of period	105,738	172,583
Cash and cash equivalents at end of period	41,362	112,667
Non-cash investing and financing activities:
Issuance of common stock in satisfaction of certain accrued employee compensation liabilities	$ 8,018	$ 7,060